TTR Amyloidosis Phase IIa results will be presented by Dr. Josep Gàmez at AAN 2016 Annual Meeting to be held in Vancouver (Canada) from 15th to 21th of April. This Clinical Trial has been performed by SOM Biotech and VHIR (Vall d’Hebron Hospital Institute of Research).

Further information about the meeting at AAN 2016 Annual Meeting

SUBCRIBE TO OUR NEWSLETTER

    Name*
    Email*


    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.